<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medvis</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская визуализация</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Visualization</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-0763</issn><issn pub-type="epub">2408-9516</issn><publisher><publisher-name>RDS-Media Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24835/1607-0763-1167</article-id><article-id custom-type="elpub" pub-id-type="custom">medvis-1167</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТЕХНОЛОГИИ ЛУЧЕВОЙ ДИАГНОСТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RADIOLOGICAL TECHNOLOGIES</subject></subj-group></article-categories><title-group><article-title>Высокотехнологичные лучевые методы в диагностике рака эндометрия – мультипараметрическая МРТ, ультразвуковая томография, 3D-ангиография, энергетическая допплерография</article-title><trans-title-group xml:lang="en"><trans-title>High-tech radiation methods in the diagnosis of endometrial cancer – multiparametric MRI, ultrasound tomography, 3D angiography, energy dopplerography</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5994-0468</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нуднов</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nudnov</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нуднов Николай Васильевич – доктор медицинских наук, профессор, заместитель директора по научной работе, заведующий НИО комплексной диагностики заболеваний и радиотерапии </p><p>117997 Москва, ул. Профсоюзная, д. 86</p></bio><bio xml:lang="en"><p>Nikolai V. Nudnov – Doct. of Sci. (Med.), Professor, Vice-Director (Science), Chief of the research institute of complex diagnostics of diseases and radiotherapy</p><p>86, Profsoyusnaya str., Moscow 117997</p></bio><email xlink:type="simple">nudnov@rncrr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9287-2636</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ивашина</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivashina</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ивашина Светлана Вячеславовна – кандидат медицинских наук, старший научный сотрудник лаборатории комплексной диагностики и лечения заболеваний органов мочеполовой и репродуктивной систем у взрослых и детей НИО хирургии, урологии, гинекологии и инвазивных технологий в онкологии </p><p>117997 Москва, ул. Профсоюзная, д. 86</p></bio><bio xml:lang="en"><p>Svetlana V. Ivashina – Cand. of Sci. (Med.), Senior Researcher, Laboratory for Comprehensive Diagnosis and Treatment of Diseases of the Genitourinary and Reproductive Systems in Adults and Children, Research Department of Surgery, Urology, Gynecology and Invasive Technologies in</p><p>Oncology</p><p>86, Profsoyusnaya str., Moscow 117997</p></bio><email xlink:type="simple">s.ivashina@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2552-5754</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аксенова</surname><given-names>С. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Aksenova</surname><given-names>S. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аксенова Светлана Павловна – кандидат медицинских наук, младший научный сотрудник лаборатории лучевой диагностики заболеваний (включая молочную железу) НИО комплексной диагностики заболеваний и радиотерапии </p><p>117997 Москва, ул. Профсоюзная, д. 86</p></bio><bio xml:lang="en"><p>Svetlana P. Aksenova – Cand. of Sci. (Med.), junior researcher of Laboratory of Radiological Diagnostics of Diseases (including the Breast) of the Research Department for Comprehensive Diagnostics of Diseases and Radiotherapy</p><p>86, Profsoyusnaya str., Moscow 117997</p></bio><email xlink:type="simple">fabella@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ “Российский научный центр рентгенорадиологии” Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Scientific Center of Roentgenoradiology of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>16</day><month>03</month><year>2023</year></pub-date><volume>27</volume><issue>2</issue><fpage>147</fpage><lpage>160</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Нуднов Н.В., Ивашина С.В., Аксенова С.П., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Нуднов Н.В., Ивашина С.В., Аксенова С.П.</copyright-holder><copyright-holder xml:lang="en">Nudnov N.V., Ivashina S.V., Aksenova S.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://medvis.rdsmedia.ru/jour/article/view/1167">https://medvis.rdsmedia.ru/jour/article/view/1167</self-uri><abstract><p>Рост заболеваемости раком эндометрия отмечается не только в постменопаузальном периоде, но и в социально активной группе женщин репродуктивного возраста начиная с 25 лет. Ультразвуковое исследование (УЗИ) и магнитно-резонансная томография (МРТ) являются основными методами неинвазивной диагностики рака эндометрия. В наше исследование было включено 69 пациенток с диагнозом рака эндометрия I–IV стадии в возрасте от 30 до 79 лет. Диагностическая информативность метода МРТ в выявлении инвазии опухоли в миометрий для всех исследуемых групп составила: чувствительность – 82,30%, специфичность – 66,6%, ПЦПР – 93,30%, ПЦОР – 40%. Диагностическая информативность ультразвукового метода по Т-критерию по системе TNM для всех групп составила: чувствительность – 91,3%, специфичность – 88,4%, ПЦПР – 88,7%, ПЦОР – 91,0%. Особенность данного исследования заключалась в оценке возможностей лучевых методов (УЗИ, МРТ) в стадировании рака эндометрия.</p></abstract><trans-abstract xml:lang="en"><p>The increase in the incidence of endometrial cancer is noted not only in postmenopausal women, but also in a socially active group of women of reproductive age, starting from 25 years. Ultrasound and magnetic resonance imaging (MRI) are the main methods of non-invasive diagnosis of endometrial cancer. Our study included 69 patients with endometrial cancer stages I–IV aged 30 to 79 years. The diagnostic informativeness of the MRI method in detecting tumor invasion into the myometrium for all groups was: sensitivity – 82.30%, specificity – 6.6%, PPV – 93.30%, NPV – 40%. The diagnostic informativeness of the ultrasound method in detecting tumor invasion into the myometrium for all groups was: sensitivity – 91.3%, specificity – 88.4%. The peculiarity of this study was to evaluate the possibilities of radiation methods (ultrasound, MRI) in the staging of endometrial cancer.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак эндометрия</kwd><kwd>малоинвазивный процесс</kwd><kwd>метастаз в лимфатические узлы</kwd><kwd>мультипараметрическая МРТ</kwd><kwd>ультразвуковая диагностика</kwd><kwd>МРТ-диагностика</kwd><kwd>ультразвуковая томография</kwd><kwd>3D-ангиография</kwd><kwd>энергетическая допплерография</kwd><kwd>М-эхо</kwd></kwd-group><kwd-group xml:lang="en"><kwd>endometrial cancer</kwd><kwd>microinvasive process</kwd><kwd>metastasis in lymph nodes</kwd><kwd>multiparametric MRI</kwd><kwd>ultrasound diagnostics</kwd><kwd>MRI diagnostics</kwd><kwd>ultrasound tomography</kwd><kwd>3D angiography</kwd><kwd>energy dopplerography</kwd><kwd>M-echo</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Злокачественные новообразования в России в 2020 г. (Заболеваемость и смертность) / Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ “НМИЦ радиологии” Минздрава России, 2021. 252 с.</mixed-citation><mixed-citation xml:lang="en">Malignant neoplasms in Russia in 2020 (morbidity and mortality) / Eds A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. M.: MNIOI im. P.A. Herzen – branch of the Federal State Budgetary Institution “NMITs Radiology” of the Ministry of Health of Russia. 2021. 252 p. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ашрафян Л.А, Огрызкова В.Л., Харченко Н.В. Ивашина С.В., Саратян А.А. Ультразвуковые критерии оценки миометральной инвазии рака эндометрия: Материалы научно-практической конференции “Современные подходы к диагностике и лечению гинекологического рака”. СПб, 2004: 12.</mixed-citation><mixed-citation xml:lang="en">Ashrafyan L.A., Ogryzkova V.L. Kharchenko N.V. Ivashina S.V., Saratyan A.A. Ultrasound criteria for assessing myometrial invasion of endometrial cancer. Proceedings of the scientific-practical conference “Modern approaches to the diagnosis and treatment of gynecological cancer”. SPb, 2004: 12. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Antonsen S.L., Jensen L.N., Loft A. et al. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer – a multicenter prospective comparative study. Gynecol. Oncol. 2013; 128 (2): 300–308. http://doi.org/10.1016/j.ygyno.2012.11.025</mixed-citation><mixed-citation xml:lang="en">Antonsen S.L., Jensen L.N., Loft A. et al. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer – a multicenter prospective comparative study. Gynecol. Oncol. 2013; 128 (2): 300–308. http://doi.org/10.1016/j.ygyno.2012.11.025</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Nougaret S., Horta M., Sala E. et al. Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology. Eur. Radiol. 2019; 29 (2): 792–805. http://doi.org/10.1007/s00330-018-5515-y</mixed-citation><mixed-citation xml:lang="en">Nougaret S., Horta M., Sala E. et al. Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology. Eur. Radiol. 2019; 29 (2): 792–805. http://doi.org/10.1007/s00330-018-5515-y</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Alcázar J.L, Gastón B., Navarro B. et al. Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with endometrial cancer: a systematic review and meta-analysis. J. Gynecol. Oncol. 2017; 28 (6): e86. https://doi.org/10.3802/jgo.2017.28.e86</mixed-citation><mixed-citation xml:lang="en">Alcázar J.L, Gastón B., Navarro B. et al. Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with endometrial cancer: a systematic review and meta-analysis. J. Gynecol. Oncol. 2017; 28 (6): e86. https://doi.org/10.3802/jgo.2017.28.e86</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lee Y.J., Moon M.H., Sung C.K. et al. MR assessment of myometrial invasion in women with endometrial cancer: discrepancy between T2-weighted imaging and contrast-enhanced T1-weighted imaging. Abdom. Radiol. (NY). 2016; 41 (1): 127–135. http://doi.org/10.1007/s00261-015-0607-5</mixed-citation><mixed-citation xml:lang="en">Lee Y.J., Moon M.H., Sung C.K. et al. MR assessment of myometrial invasion in women with endometrial cancer: discrepancy between T2-weighted imaging and contrast-enhanced T1-weighted imaging. Abdom. Radiol. (NY). 2016; 41 (1): 127–135. http://doi.org/10.1007/s00261-015-0607-5</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Deng L., Wang Q.P., Chen X. et al. The Combination of Diffusion- and T2-Weighted Imaging in Predicting Deep Myometrial Invasion of Endometrial Cancer: A Systematic Review and Meta-Analysis. J. Comput. Assist. Tomogr. 2015; 39 (5): 661–673. http://doi.org/10.1097/RCT.0000000000000280</mixed-citation><mixed-citation xml:lang="en">Deng L., Wang Q.P., Chen X. et al. The Combination of Diffusion- and T2-Weighted Imaging in Predicting Deep Myometrial Invasion of Endometrial Cancer: A Systematic Review and Meta-Analysis. J. Comput. Assist. Tomogr. 2015; 39 (5): 661–673. http://doi.org/10.1097/RCT.0000000000000280</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Andreano A., Rechichi G., Rebora P. et al. MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis. Eur. Radiol. 2014; 24 (6): 1327–1338. http://doi.org/10.1007/s00330-014-3139-4</mixed-citation><mixed-citation xml:lang="en">Andreano A., Rechichi G., Rebora P. et al. MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis. Eur. Radiol. 2014; 24 (6): 1327–1338. http://doi.org/10.1007/s00330-014-3139-4</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Steiner A., Alban G., Cheng T. et al. Vaginal recurrence of endometrial cancer: MRI characteristics and correlation with patient outcome after salvage radiation therapy. Abdom. Radiol. (NY). 2020; 45 (4): 1122–1131. http://doi.org/10.1007/s00261-020-02453-2</mixed-citation><mixed-citation xml:lang="en">Steiner A., Alban G., Cheng T. et al. Vaginal recurrence of endometrial cancer: MRI characteristics and correlation with patient outcome after salvage radiation therapy. Abdom. Radiol. (NY). 2020; 45 (4): 1122–1131. http://doi.org/10.1007/s00261-020-02453-2</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Нуднов Н.В., Аксенова С.П., Крейнина Ю.М., Котляров П.М. Магнитно-резонансная томография в диагностике вторичного опухолевого поражения влагалища. Вестник рентгенологии и радиологии. 2015; 3: 37–46. PMID: 26302621</mixed-citation><mixed-citation xml:lang="en">Nudnov N.V., Aksenova S.P., Kreĭnina Iu.M, Kotliarov P.M. [Magnetic resonance imaging in the diagnosis of secondary vaginal tumor involvement]. Journal of Radiology and Nuclear Medicine. 2015; 3: 37–45. PMID: 26302621 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Аксенова C.П., Нуднов Н.В., Крейнина Ю.М. Магнитно-резонансная визуализация влагалища и малого таза у женщин, перенесших противоопухолевое лечение по поводу рака женских половых органов. Медицинская визуализация. 2017; 21 (2): 131–139. http://doi.org/10.24835/1607-0763-2017-2-131-139</mixed-citation><mixed-citation xml:lang="en">Aksenova S.P., Nudnov N.V., Kreinina Yu.M. Magnetic resonance imaging of the vagina and small pelvis in women undergoing antitumor treatment for cancer of the female genital organs. Medical Visualization. 2017; 21 (2): 131–139. http://doi.org/10.24835/1607-0763-2017-2-131-139 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ашрафян Л.А. Стандартизованная диагностика рака эндометрия: Дис... д-ра мед. наук. М., 1989.</mixed-citation><mixed-citation xml:lang="en">Ashrafyan L.A. Standardized diagnosis of endometrial cancer: Dis... doct. of med. sci. M., 1989. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Бохман Я.В. Особенности клинического течения рака тела матки. Современные проблемы онкологии. Л., 1969: 70–78.</mixed-citation><mixed-citation xml:lang="en">Bohman Ya.V. Features of the clinical course of uterine body cancer. Modern problems of oncology. Leningrad, 1969: 70–78. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А.Д., Ашрафян Л.А., Стилиди И.С. Онкогинекология: Национальное руководство. М.: ГЭОТАР-Медиа, 2019. 384 с.</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Ashrafyan L.A., Stilidi I.S. Oncogynecology: National leadership. M.: GEOTAR-Media, 2019. 384 p. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Boothe D., Wolfson A., Christensen M. et al. Lymphovascular Invasion in Endometrial Cancer: Prognostic Value and Implications on Adjuvant Radiation Therapy Use. Am. J. Clin. Oncol. 2019; 42 (7): 549–554. https://doi.org/10.1097/COC.0000000000000559</mixed-citation><mixed-citation xml:lang="en">Boothe D., Wolfson A., Christensen M. et al. Lymphovascular Invasion in Endometrial Cancer: Prognostic Value and Implications on Adjuvant Radiation Therapy Use. Am. J. Clin. Oncol. 2019; 42 (7): 549–554. https://doi.org/10.1097/COC.0000000000000559</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ашрафян Л.А., Антонова И.Б., Огрызкова В.Л., Бабаева Н.А., Басова И.О., Моцкобили Т.А., Мягкова А.А. Клинико-морфологическое обоснование микроинвазивного рака эндометрия. Сибирский онкологический журнал. 2007; Приложение: 9–15.</mixed-citation><mixed-citation xml:lang="en">Ashrafjan L.A., Antonova I.B., Ogryzkova V.L., Babaeva N.A., Basova I.O., Mockobili T.A., Mjagkova A.A. Clinical and morphological substantiation of microinvasive endometrial cancer. Siberian Journal of Oncology. 2007; Suppl.: 9–15. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Otero-García M.M., Mesa-Álvarez A., Nikolic O. et al. Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers. Insights. Imaging. 2019; 10 (1): 19. http://doi.org/10.1186/s13244-019-0696-8</mixed-citation><mixed-citation xml:lang="en">Otero-García M.M., Mesa-Álvarez A., Nikolic O. et al. Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers. Insights. Imaging. 2019; 10 (1): 19. http://doi.org/10.1186/s13244-019-0696-8</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Naftalin J., Jurkovic D. The endometrial-myometrial junction: a fresh look at a busy crossing. Ultrasound Obstet. Gynecol. 2009; 34 (1): 1–11. https://doi.org/10.1002/uog.6432</mixed-citation><mixed-citation xml:lang="en">Naftalin J., Jurkovic D. The endometrial-myometrial junction: a fresh look at a busy crossing. Ultrasound Obstet. Gynecol. 2009; 34 (1): 1–11. https://doi.org/10.1002/uog.6432</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Moatasim A., Hameed Z., Ahmad I. Assessment of lymphovascular invasion in early stage endometrial carcinoma – a retrospective study. Surg. Exp. Pathol. 2021; 4: 9. https://doi.org/10.1186/s42047-021-00091-6</mixed-citation><mixed-citation xml:lang="en">Moatasim A., Hameed Z., Ahmad I. Assessment of lymphovascular invasion in early stage endometrial carcinoma – a retrospective study. Surg. Exp. Pathol. 2021; 4: 9. https://doi.org/10.1186/s42047-021-00091-6</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">van der Putten L.J., van de Vijver K., Bartosch C. et al. Reproducibility of measurement of myometrial invasion in endometrial carcinoma. Virchows Arch. 2017; 470 (1): 63–68. https://doi.org/10.1007/s00428-016-2035-5</mixed-citation><mixed-citation xml:lang="en">van der Putten L.J., van de Vijver K., Bartosch C. et al. Reproducibility of measurement of myometrial invasion in endometrial carcinoma. Virchows Arch. 2017; 470 (1): 63–68. https://doi.org/10.1007/s00428-016-2035-5</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kondalsamy-Chennakesavan S., van Vugt S., Sanday K. et al. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer. Int. J. Gynecol. Cancer. 2010; 20 (7): 1217–1221. https://doi.org/10.1111/igc.0b013e3181ef0a31</mixed-citation><mixed-citation xml:lang="en">Kondalsamy-Chennakesavan S., van Vugt S., Sanday K. et al. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer. Int. J. Gynecol. Cancer. 2010; 20 (7): 1217–1221. https://doi.org/10.1111/igc.0b013e3181ef0a31</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Veade A.E., Foote J., Ehrisman J. et al. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma. Wld J. Surg. Oncol. 2019; 17 (1): 80. https://doi.org/10.1186/s12957-019-1620-x</mixed-citation><mixed-citation xml:lang="en">Veade A.E., Foote J., Ehrisman J. et al. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma. Wld J. Surg. Oncol. 2019; 17 (1): 80. https://doi.org/10.1186/s12957-019-1620-x</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Oliver-Perez M.R., Magriña J., Villalain-Gonzalez C. et al. Lymphovascular space invasion in endometrial carcinoma: Tumor size and location matter. Surg. Oncol. 2021; 37: 101541. https://doi.org/10.1016/j.suronc.2021.101541</mixed-citation><mixed-citation xml:lang="en">Oliver-Perez M.R., Magriña J., Villalain-Gonzalez C. et al. Lymphovascular space invasion in endometrial carcinoma: Tumor size and location matter. Surg. Oncol. 2021; 37: 101541. https://doi.org/10.1016/j.suronc.2021.101541</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Geels Y.P., Pijnenborg J.M., van den Berg-van Erp SH, Snijders MP, Bulten J, Massuger LF. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%. Gynecol. Oncol. 2013; 129 (2): 285–291. https://doi.org/10.1016/j.ygyno.2013.02.013</mixed-citation><mixed-citation xml:lang="en">Geels Y.P., Pijnenborg J.M., van den Berg-van Erp SH, Snijders MP, Bulten J, Massuger LF. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%. Gynecol. Oncol. 2013; 129 (2): 285–291. https://doi.org/10.1016/j.ygyno.2013.02.013</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Faria S.C., Devine C.E., Rao B. et al. Imaging and Staging of Endometrial Cancer. Semin. Ultrasound CT MR. 2019; 40 (4): 287–294. http://doi.org/10.1053/j.sult.2019.04.001</mixed-citation><mixed-citation xml:lang="en">Faria S.C., Devine C.E., Rao B. et al. Imaging and Staging of Endometrial Cancer. Semin. Ultrasound CT MR. 2019; 40 (4): 287–294. http://doi.org/10.1053/j.sult.2019.04.001</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Bi Q., Chen Y., Chen J. et al. Predictive value of T2-weighted imaging and dynamic contrast-enhanced MRI for assessing cervical invasion in patients with endometrial cancer: a meta-analysis. Clin. Imaging. 2021; 78: 206–213. http://doi.org/10.1016/j.clinimag.2021.05.014</mixed-citation><mixed-citation xml:lang="en">Bi Q., Chen Y., Chen J. et al. Predictive value of T2-weighted imaging and dynamic contrast-enhanced MRI for assessing cervical invasion in patients with endometrial cancer: a meta-analysis. Clin. Imaging. 2021; 78: 206–213. http://doi.org/10.1016/j.clinimag.2021.05.014</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
